T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
The competent immune system controls disease effectively due to induction, function, and regulation of effector lymphocytes. Immunosurveillance is exerted mostly by cytotoxic T-lymphocytes (CTLs) while specific immune suppression is associated with tumor malignancy and progression. In squamous cell...
Saved in:
Main Authors: | A. E. Albers, L. Strauss, T. Liao, T. K. Hoffmann, A. M. Kaufmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/236378 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma (HNSC) for the Exploration of Immunotherapy and Prognosis
by: Chunli Huang, et al.
Published: (2022-01-01) -
Development and validation of the modified index of fragility in head and neck cancer surgery
by: Koorosh Semsar-Kazerooni, et al.
Published: (2023-01-01) -
Sarcopenia in head and neck cancer: A scoping review.
by: Nedeljko Jovanovic, et al.
Published: (2022-01-01) -
Genome Stability Pathways in Head and Neck Cancers
by: Glenn Jenkins, et al.
Published: (2013-01-01) -
Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer
by: Marisa Shiina, et al.
Published: (2015-01-01)